Exjade

Exjade information and resources from the National Cancer Institute

NCI Thesaurus | Exjade

(Other name for: deferasirox)NCI Thesaurus | Exjade

(Other name for: deferasirox)



news articles



Novartis Oncology - Highlights of Key Data Presented at ASH 2005 ... Dec 14, 2005
Business Wire (press release), CML. In AMN107, the Co. saw confirmation of a strong Phase I activity. Exjade is now available in the US and Switzerland. Femara ...

Deferasirox - First Oral Drug for Chronic Iron Overload Nov 19, 2005
RxPG NEWS, By US Food and Drug Administration (FDA), The US Food and Drug Administration (FDA) recently announced the approval of Exjade (deferasirox), an oral iron ...

Novartis Oncology - Highlights of Key Data Presented at ASH 2005 ... Dec 14, 2005
Business Wire (press release), CML. In AMN107, the Co. saw confirmation of a strong Phase I activity. Exjade is now available in the US and Switzerland. Femara ...

Deferasirox - First Oral Drug for Chronic Iron Overload Nov 19, 2005
RxPG NEWS, By US Food and Drug Administration (FDA), The US Food and Drug Administration (FDA) recently announced the approval of Exjade (deferasirox), an oral iron ...


Home | About | Search topics | Cancers | Treatment | Medications
Onconews provides free news and resources on cancer-related topics.

Copyright onconews.org 2005-2006.
All Rights Reserved.
Google
 
Web onconews.org